J&J sues Amgen over plan to sell drug similar to blockbuster Stelara
Source: Reuters
Nov 30 (Reuters) - Johnson & Johnson's (JNJ.N) Janssen unit has sued Amgen Inc (AMGN.O) over its plan to market a drug for ulcerative colitis and other conditions similar to J&J's top-selling Stelara, saying it would infringe two patents in a lawsuit made public on Wednesday.Stelara accounted for $9.1 billion of J&J's $52 billion in global drug sales last year. Sales for the first nine months of this year were…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at Reuters